Genetic ‘fingerprint’ may ID breast cancer patients likely to benefit from potentially toxic chemo!

Anthracyclines can be effective against breast cancer but often have toxic side effects. Stanford researchers used gene expression levels to identify women most likely to benefit from the drugs, regardless of breast cancer type or stage.

Full Story:

chemo!